IRCT201212206975N3已完成2 期
A randomized, double-blind, placebo-controlled pilot study of the efficacy of alendronate on the prevention of bone loss in patients with early ankylosing spondylitis
Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Schober index=5; Normal hip joint in the pelvic radiography; Absence or rarity of syndesmophyte in the spine radiography (Taylor index=1); Normal bone density or mild osteopenia (T-score=-1.5)
- •Exclusion criteria:
- •Use of drugs which increase bone density like bisphosphonates; Use of steroids and biological agents; Coexistence of other disease which decreases bone density: including hyperparathyroidism, diabetes, hyper and hypothyroidism, osteomalasia, liver failure, renal failure
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Effect of centhaquine on cardiovascular parameters in patients with hypovolemic shock.CTRI/2023/12/060444Aman Hospital and Research Centre
进行中（未招募）
1 期
A Randomized pilot study to evaluate the safety and efficacy of Cinryze (C1-Esterase Inhibitor (human)) for the treatment of graft rejection in kidney transplant patientsEUCTR2012-000441-12-DEVIROPHARMA Incorporated20
进行中（未招募）
不适用
A Randomized, double-blind, placebo-controlled pilot study of KB001 in mechanically-ventilated patients colonized with pseudomonas aeruginosaEUCTR2007-006764-29-FRKaloBios Pharmaceuticals, Inc.
进行中（未招募）
1 期
Passion flower and stressSince only healthy volunteers will be included in this study, there is no medical condition to be examined. The indication for PASCOFLAIR® is nervous restlessness, a subclinical state of stress-sensitivity.EUCTR2011-006129-17-DEPASCOE Pharmazeutische Präparate GmbH60
进行中（未招募）
不适用
Investigating the potential health benefits of ergothioneine supplementation for people with metabolic syndromeISRCTN25890011niversity of Leeds108